Risk factors of acute graft-versus-host disease (AGVHD) after allogeneic bone marrow transplantation using an matched unrelated donor (MUD) and prophylaxis with taclorimus (FK506) and methotrexate (MTX)

被引：0
|
作者：
Iguchi, T
Okamoto, S
Mori, T
Watanabe, R
Sato, N
Nagayama, H
Takayama, N
Ikeda, Y
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P654
引用
收藏
页码：S172 / S173
页数：2
相关论文
共 50 条
  • [31] Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies
    JP Uberti
    SM Silver
    PT Adams
    P Jacobson
    A Scalzo
    V Ratanatharathorn
    Bone Marrow Transplantation, 1997, 19 : 1233 - 1238
  • [32] Phase III study comparing tacrolimus (FK506) with cyclosporine (CSP) for prophylaxis of acute graft-versus-host disease (GVHD) after marrow transplantation from unrelated donors.
    Nash, RA
    Antin, J
    Karanes, C
    Fay, J
    Avalos, B
    Yeager, AM
    Przepiorka, D
    Davies, S
    Petersen, F
    Buell, D
    Fitzsimmons, W
    Bartels, P
    Hansen, J
    Anasetti, C
    Storb, R
    Ratanatharathorn, V
    BLOOD, 1997, 90 (10) : 2499 - 2499
  • [33] ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PERREAULT, C
    GYGER, M
    BOILEAU, J
    BONNY, Y
    COUSINEAU, S
    LACOMBE, M
    LAVALLEE, R
    TAWIL, E
    DANGELO, G
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1983, 129 (09) : 969 - 974
  • [34] Prophylaxis of graft-versus-host disease (GVHD) with tacrolimus and methotrexate after allogeneic bone marrow transplantation (BMT) from unrelated donor: Impact of blood level of tacrolimus on the development of acute GVHD
    Mori, T
    Nakazato, T
    Aisa, Y
    Yamazaki, R
    Ikeda, Y
    Okamoto, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 65 - 65
  • [35] Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation
    Kean, Leslie S.
    Burns, Linda J.
    Kou, Tzuyung D.
    Kapikian, Roxanne
    Lozenski, Karissa
    Langston, Amelia
    Horan, John T.
    Watkins, Benjamin
    Qayed, Muna
    Bratrude, Brandi
    Betz, Kayla
    Tang, Xiao-Ying
    Zhang, Mei-Jie
    Connolly, Sean E.
    Polinsky, Martin
    Gavin, Brian
    Gomez-Caminero, Andres
    Pasquini, Marcelo C.
    BLOOD, 2024, 144 (17) : 1834 - 1845
  • [36] Prophylaxis of acute hepatic graft-versus-host disease with ursodeoxycholic acid in allogeneic bone marrow transplantation
    Iwata, N
    Nakamura, Y
    Masui, H
    Seto, Y
    Takemoto, Y
    Kakishita, E
    HEPATOLOGY, 1997, 26 (04) : 1091 - 1091
  • [37] FK506 (TACROLIMUS) IN THE TREATMENT OF STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION
    KOEHLER, MT
    HOWRIE, D
    MIRRO, J
    NEUDORF, S
    BLATT, J
    COREY, S
    WOLLMAN, M
    KELLYEKEROTH, V
    REYES, J
    BONE MARROW TRANSPLANTATION, 1995, 15 (06) : 895 - 899
  • [38] RISK-FACTORS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN HISTOCOMPATIBLE DONOR BONE-MARROW TRANSPLANTATION
    WEISDORF, D
    HAKKE, R
    BLAZAR, B
    MILLER, W
    MCGLAVE, P
    RAMSAY, N
    KERSEY, J
    FILIPOVICH, A
    TRANSPLANTATION, 1991, 51 (06) : 1197 - 1203
  • [39] Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors
    Martin, P
    Bleyzac, N
    Souillet, G
    Galambrun, C
    Bertrand, Y
    Maire, PH
    Jelliffe, RW
    Aulagner, G
    BONE MARROW TRANSPLANTATION, 2003, 32 (09) : 881 - 887
  • [40] Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors
    P Martin
    N Bleyzac
    G Souillet
    C Galambrun
    Y Bertrand
    P H Maire
    R W Jelliffe
    G Aulagner
    Bone Marrow Transplantation, 2003, 32 : 881 - 887
12345